Bristol-Myers Squibb has reached a deal to pay $89 million to settle four lawsuits related to inflated inventories and other …
The hepatitis B market will double in size by 2010 and hit sales of $1 billion, according to analysts Datamonitor. …
Practice based commissioning looks set to have a major impact on how pharma companies organise their salesforces and promote and …
Since the advent of brick sales information, numerous analytical techniques have become available to help identify the most valuable customers …
GlaxoSmithKline has set up its eighth R&D Centre of Excellence which will focus on building partnerships with biotech firms, academia …
The ABPI has welcomed a new report on the ethics of animal research, agreeing the industry must challenge the need …
Pharmaceutical companies should increase their investment in community pharmacists, according to a leading pharmacy spokesperson.Michael Holden, NHS development manager at …
Five years into the programme of reforms started with the NHS Plan, attention has turned to the services provided by …
Pfizer looks set to become a serious contender in oncology with its promising phase III kidney cancer drug Sutent.Until now …
Pharma and biotech companies presented a welter of data at this year's ASCO cancer conference, highlighting the growing importance of …
Global procurement processes don't deliver best value and are frequently flawed, according to speakers at the Pharmaceutical Society's annual Question …
Shire Pharmaceuticals hopes to strengthen its ADHD portfolio and establish itself in the global gastrointestinal market with a number of …
AstraZeneca has made a key appointment to its global PR for its statin brand Crestor.Ben Strutt spent six years as …